Many of the cases of colon cancer present early symptoms similar to those of IBS, or irritable bowel syndrome, since both ...
The FDA has updated the label indication for linaclotide capsules for the treatment of irritable bowel syndrome with ...
The Food and Drug Administration (FDA) has approved Linzess ® (linaclotide) for the treatment of irritable bowel syndrome with constipation (IBS-C) in patients 7 years of age and older. Previously, ...
The FDA has approved Linzess (linaclotide) for children aged 7 and older with IBS-C, marking the first FDA-approved drug for ...
B. Longum is known as a “good bacteria” that helps break down food and absorb nutrients, which can help ease digestive ...
The US Food and Drug Administration (FDA) has approved Linzess (linaclotide) as the first treatment for children living with ...
The FDA expands use of linaclotide to children as young as age 7 years with irritable bowel syndrome with constipation (IBS-C ...
The US medicines regulator has approved Linzess (linaclotide) capsules for children aged seven years and older with irritable ...
Rifaximin is as effective as the low-FODMAP diet in managing irritable bowel syndrome and offers quicker symptom relief and ...
For millions, this is the reality of living with IBS – a syndrome that is experienced by approximately 4-11% of the global ...